Abbott Laboratories (ABT)
Net profit margin
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 5,723,000 | 5,162,000 | 5,161,000 | 5,804,000 | 6,933,000 | 7,889,000 | 8,554,000 | 7,725,000 | 7,071,000 | 7,244,000 | 6,376,000 | 5,724,000 | 4,495,000 | 3,382,000 | 3,110,000 | 3,579,000 | 3,687,000 | 3,292,000 | 2,895,000 | 2,622,000 |
| Revenue (ttm) | US$ in thousands | 39,431,000 | 39,324,000 | 39,587,000 | 40,914,000 | 43,093,000 | 44,485,000 | 45,026,000 | 43,990,000 | 42,541,000 | 41,768,000 | 39,700,000 | 36,806,000 | 34,070,000 | 31,814,000 | 30,993,000 | 31,613,000 | 31,389,000 | 30,840,000 | 30,313,000 | 30,061,000 |
| Net profit margin | 14.51% | 13.13% | 13.04% | 14.19% | 16.09% | 17.73% | 19.00% | 17.56% | 16.62% | 17.34% | 16.06% | 15.55% | 13.19% | 10.63% | 10.03% | 11.32% | 11.75% | 10.67% | 9.55% | 8.72% |
December 31, 2023 calculation
Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $5,723,000K ÷ $39,431,000K
= 14.51%
Based on the data provided for Abbott Laboratories' net profit margin over the past eight quarters, we observe fluctuations in the company's profitability. The net profit margin decreased from 15.88% in Q4 2022 to 14.27% in Q4 2023, indicating a decline in the company's ability to convert revenue into profit. This downtrend continued in Q1 and Q2 2023, with net profit margins of 13.98% and 12.83% respectively.
In Q3 2023, there was a slight improvement in the net profit margin to 12.92%, although it remained below the levels seen in the previous year. This suggests that Abbott Laboratories may be facing challenges in controlling costs and managing operating expenses during this period.
Comparing the most recent quarters to the same periods in the prior year, we observe a downward trend in net profit margins. The company's profitability peaked in Q2 2022 at 18.78% and has been on a declining trajectory since then.
Overall, Abbott Laboratories' net profit margin performance indicates some variability and a general decline in profitability over the past year. Further analysis of the company's cost structure and revenue generation may provide insights into the factors contributing to these fluctuations in profitability.
Peer comparison
Dec 31, 2023